Viability, proliferation and adhesion of smooth muscle cells and human umbilical vein endothelial cells on electrospun polymer scaffolds

Clinical Hemorheology and Microcirculation

Volumn 50, Issue 1-2, 2012, Pages 101-112

  Rüder, Constantin ^a,b   Sauter, Tilman ^a,b,c   Becker, Tino ^c   Kratz, Karl ^a,b,c   Hiebl, Bernhard ^a,b,c   Jung, Friedrich ^a,b,c   Lendlein, Andreas ^a,b,c   Zohlnhöefer, Dietlind ^a,b  

^a Berlin Brandenburg Center for Regenerative Therapies   (Germany)

^b Institute of Polymer Research   (Germany)

^c INSTITUTE OF MATERIALS RESEARCH   (Germany)

Author keywords

cell selectivity; degradable polymer; drug eluting stent; electrospinning; Endothelialization

Indexed keywords

COPOLYMER; POLY(4 DIOXANONE); POLY(VINYLIDENE FLUORIDE CO HEXAFLUOROPROPENE); POLYETHERESTERURETHANE; POLYETHERIMIDE; POLYMER; UNCLASSIFIED DRUG;

APOPTOSIS; ARTERY WALL; ARTICLE; CELL ADHESION; CELL CYCLE; CELL INTERACTION; CELL PROLIFERATION; CELL VIABILITY; DRUG ELUTING STENT; ELECTROSPINNING; HUMAN; HUMAN CELL; IMPLANTATION; INFLAMMATION; MATERIAL COATING; SMOOTH MUSCLE FIBER; STENT THROMBOSIS; SURFACE PROPERTY; UMBILICAL VEIN ENDOTHELIAL CELL;

CELL ADHESION; CELL DIVISION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DIOXANES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MYOCYTES, SMOOTH MUSCLE; POLYESTERS; POLYMERS; POLYURETHANES; POLYVINYLS; STENTS; TISSUE SCAFFOLDS;

EID: 84858684854     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-2011-1447     Document Type: Article

References (24)

1. Anonymous, Ethical guidelines for publication in clinical hemorheology and microcirculation, Clinical Hemorheology and Microcirculation 44 (2010), 1-2.
2. N.L. Angeloni, et al., Regeneration of the cavernous nerve by Sonic hedgehog using aligned peptide amphiphile nanofibers, Biomaterials 32 (2011), 1091-1101.
3. M. Behl, U. Ridder, Y. Feng, S. Kelch and A. Lendlein, Shape-memory capability of binary multiblock copolymer blends with hard and switching domains provided by different components, Soft Matter 5 (2009), 676-684.
4. S. Bezenek, et al., Low stent thrombosis risk with the XIENCE V(R) everolimus-eluting coronary stent: Evidence from randomized and single-arm clinical trials, J Interv Cardiol 24 (2011), 326-341.
5. S. Braune, M. Lange, K. Richau, K. Lutzow, T. Weigel, F. Jung and A. Lendlein, Interaction of thrombocytes with poly(ether imide): The influence of processing, Clin Hemorheol Microcirc 46 (2010), 239-250.
6. G.D. Dangas, B.E. Claessen, A. Caixeta, E.A. Sanidas, G.S. Mintz, R. Mehran, Instent restenosis in the drug-eluting stent era, J Am Coll Cardiol 56 (2010), 1897-1907.
7. Y. Feng, M. Behl, S. Kelch, A. Lendlein, Biodegradable multiblock copolymers based on oligodepsipeptides with shapememory properties, Macromol Biosci 9 (2009), 45-54.
8. H. Grablowitz, A. Lendlein, Synthesis and characterization of α,ω-dihydroxy-telechelic oligo(p-dioxanone), J Mater Chem 17 (2007), 4050-4065.
9. L.G. Griffith, Emerging design principles in biomaterials and scaffolds for tissue engineering, Ann N Y Acad Sci 961 (2002), 83-95. (Pubitemid 34721746)
10. B. Hiebl, R. Fuhrmann, F. Jung, K. Kratz, A. Lendlein, R.P. Franke, Degradation of and angiogenesis around multiblock copolymers containing poly(p-dioxanone)- and poly(epsilon-caprolactone)-segments subcutaneously implanted in the rat neck, Clin Hemorheol Microcirc 45 (2010), 117-122.
11. R. Hill, et al., Coronary artery stents: A rapid systematic review and economic evaluation, Health Technol Assess 8 (2004), iii-iv, 1-242.
12. M. Joner, et al., Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk, J Am Coll Cardiol 48 (2004), 193-202. (Pubitemid 43929240)
13. F. Jung, C. Wischke and A. Lendlein, Degradable, multifunctional cardiovascular implants: Challenges and hurdles, MRS Bulletin 35 (2010), 607-613.
14. C. Kaiser, et al., Drug-eluting versus bare-metal stents in large coronary arteries, New Engl J Med 363 (2010), 2310-2319.
15. K. Kratz, R. Habermann, T. Becker, K. Richau, A. Lendlein, Shape-memory properties and degradation behavior of multifunctional electro-spun scaffolds, Int J Artif Organs 34 (2011), 225-230.
16. A. Kulkarni, J. Reiche, J. Hartmann, K. Kratz, A. Lendlein, Selective enzymatic degradation of poly(epsilon-caprolactone) containing multiblock copolymers, Eur J Pharm Biopharm 68 (2008), 46-56. (Pubitemid 350181417)
17. N. Langwieser, J.B. Schwarz, C. Reichenbacher, B. Stemmer, S. Massberg, N.N. Langwieser, D. Zohlnhofer, Role of bone marrow-derived cells in the genetic control of restenosis, Arterioscler Thromb Vasc Biol 29 (2009), 1551-1557.
18. A. Lendlein, R. Langer, Biodegradable, elastic shape-memory polymers for potential biomedical applications, Science 296 (2002), 1673-1676. (Pubitemid 34580574)
19. A. Lendlein, M. Behl, B. Hiebl, C.Wischke, Shape-memory polymers as a technology platform for biomedical applications, Expert Rev Med Devic 7 (2010), 357-379.
20. S. Liao, B. Li, Z. Ma, H. Wei, C. Chan and S. Ramakrishna, biomimetic electrospun nanofibers for tissue regeneration, Biomed Mater 1 (2006), R45-R53. (Pubitemid 44529331)
21. N. Scharnagl, S. Lee, B. Hiebl, A. Sisson and A. Lendlein, Design principles for polymers as substratum for adherent cells, J Mater Chem 20 (2010), 8789-8802.
22. P.W. Serruys, et al., Angiographic follow-up after placement of a self-expanding coronary-artery stent, N Engl J Med 324 (1991), 13-17.
23. R. Tzoneva, B. Seifert, W. Albrecht, K. Richau, T. Groth, A. Lendlein, 2008. Hemocompatibility of poly(ether imide) membranes functionalized with carboxylic groups, J Mater Sci Mater Med 19 (2008), 3203-3210.
24. R. Tzoneva, B. Seifert,W. Albrecht, K. Richau, A. Lendlein, T. Groth, Poly(ether imide) membranes: Studies on the effect of surface modification and protein pre-adsorption on endothelial cell adhesion, growth and function, J Biomater Sci Polym Ed 19 (2008), 837-852.